Candel Therapeutics, Inc.

CADL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$55-$38-$19-$36
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$12
Stock-Based Comp.$5$3$2$3
Change in WC$0-$0$0-$1
Other Non-Cash$22-$0-$16$0
Operating Cash Flow-$27-$34-$31-$22
Investing Activities
PP&E Inv.-$0-$0-$1-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$1-$2
Financing Activities
Debt Repay.-$9$0$20$0
Stock Issued$102$0$0$71
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$0$0$0
Financing Cash Flow$94-$0$20$72
Forex Effect$0$0$0$0
Net Chg. in Cash$67-$35-$13$48
Supplemental Information
Beg. Cash$36$70$83$35
End Cash$103$36$70$83
Free Cash Flow-$27-$35-$33-$24
Candel Therapeutics, Inc. (CADL) Financial Statements & Key Stats | AlphaPilot